COLLABORATION AND EXCLUSIVE LICENSE AGREEMENTCollaboration and Exclusive License Agreement • May 10th, 2021 • Novavax Inc • Biological products, (no disgnostic substances)
Collaboration and License Agreement Between SK Bioscience Co., Ltd. and Novavax, Inc. Dated February 12, 2021Collaboration and License Agreement • May 10th, 2021 • Novavax Inc • Biological products, (no disgnostic substances)
This Collaboration and License Agreement (this “Agreement”) is entered into as of February 12, 2021 (the “Effective Date”) by and between Novavax, Inc., a Delaware corporation having a place of business at 21 Firstfield Rd., Gaithersburg, MD 20878 (“Novavax”) and SK bioscience Co., Ltd., a company incorporated in the Republic of Korea having a place of business at 310 Pangyo-ro, Seongnam-si, Gyeonggi-do, 134949, Republic of Korea (“SK”). Novavax and SK may, from time to time, be individually referred to as a “Party” and collectively referred to as the “Parties.”
